Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

A surprising acne rosacea remedy

Martin C. Young, MD
Conditions
November 6, 2023
Share
Tweet
Share

I have typically managed my mild case of acne rosacea (AR) with affordable over-the-counter (OTC) medications, but there has always been a residual redness that bothered me.

Recently, while reading about Demodex, microscopic mites that live on the faces of many of us in our hair follicles and sebaceous glands, I became interested in their potential connection to AR. I wondered if a topical mitocidal treatment might be helpful. Some research confirmed that ivermectin was indeed effective in treating AR.

So, I decided to acquire some.

As a pediatrician, I’m familiar with ivermectin because it’s used to treat head lice, a common childhood complaint. It was once available only by prescription but is now available over the counter as a lotion, priced at around $35.

I delved deeper into my research and soon discovered that AR treatment involved a 1% ivermectin cream, available in both brand and generic versions.

I consulted my Medicare Part D drug list and was shocked by the cost I would have to bear, especially considering that it was only available through a “step therapy” process, which required trying other cheaper medications first. So, I turned to the GoodRx website, which indicated an “average retail price” of $567 but promised that, with their coupon, I could obtain a small tube (45 g, enough for one month) for anywhere between $140 to $280. The Amazon online pharmacy quoted $509 for the brand Soolantra and $379 for the generic version.

Are you kidding me? Could I not find access to this straightforward medication, which has been in medical use since 1987 (and earned its inventor a Nobel Prize)? I scoured Amazon and found numerous options for a veterinary preparation used to deworm horses; a 6 g tube of 1.82% ivermectin was as cheap as $12! I wondered if I could use this topically for my AR.

Further research revealed that this was indeed a common practice among AR sufferers who faced the exorbitant cost of the human topical product. Some articles even included interviews with dermatologists who disapproved of the practice, albeit for safety reasons. One couldn’t help but wonder if they were protecting their interests.

So, I purchased some of the horse paste, which had a pleasant apple scent (and apparently, a taste for horses). Before applying it, I mixed it half and half with some hand cream from the dollar store ($1.25). I can confidently report a noticeable improvement in redness after only a few days. By the two-month mark, my AR had disappeared.

Why then is 1% ivermectin cream, whether brand or generic, so expensive? Clearly, it’s not due to the cost of the ingredients. I’m sure that if a representative of the Soolantra brand were questioned, they would mention expenses related to research, safety trials, and the like. My response would be, “Can you please explain why I can obtain your product through a legitimate government-regulated online pharmacy in the U.K. for about $40?” I’d watch them blush.

It’s hard to escape the conclusion that Big Pharma is once again taking advantage of us Americans.

Martin C. Young is a pediatric endocrinologist.

Prev

Empowering health care professionals through mindfulness [PODCAST]

November 5, 2023 Kevin 0
…
Next

Antisemitism is at a historic high not just in other countries, but right here in America

November 6, 2023 Kevin 7
…

ADVERTISEMENT

Tagged as: Dermatology

Post navigation

< Previous Post
Empowering health care professionals through mindfulness [PODCAST]
Next Post >
Antisemitism is at a historic high not just in other countries, but right here in America

ADVERTISEMENT

More by Martin C. Young, MD

  • Is there a place for audiovisual recording in medicine?

    Martin C. Young, MD
  • My battle with atrial fibrillation

    Martin C. Young, MD
  • What happened to the chemical pathologist?

    Martin C. Young, MD

Related Posts

  • Chlorophyll, acne, and TikTok: Should these mix?

    Casey Paul Schukow and Vanessa Tan
  • 3 surprising links to medical errors

    Health eCareers
  • The surprising impact of medical students on patients

    Nicole Cifra, MD, MPH
  • The evolution of medical training in dermatology and the impact of technology

    Peter Lio, MD
  • How to match into dermatology: A medical student shares her success story

    Jenny Wang
  • More than skin deep: the importance of culturally competent care in medical education

    Grace Shadid

More in Conditions

  • Why senior-friendly health materials are essential for access

    Gerald Kuo
  • Why smoking is the top cause of bladder cancer

    Martina Ambardjieva, MD, PhD
  • How regulations restrict long-term care workers in Taiwan

    Gerald Kuo
  • The obesity care gap for U.S. women

    Eliza Chin, MD, MPH, Kathryn Schubert, MPP, Millicent Gorham, PhD, MBA, Elizabeth Battaglino, RN-C, and Ramsey Alwin
  • What heals is the mercy of being heard

    Michele Luckenbaugh
  • Why police need Parkinson’s disease training

    George Ackerman, PhD, JD, MBA
  • Most Popular

  • Past Week

    • Why feeling unlike yourself is a sign of physician emotional overload

      Stephanie Wellington, MD | Physician
    • Accountable care cooperatives: a community-owned health care fix

      David K. Cundiff, MD | Policy
    • How should kratom be regulated? [PODCAST]

      The Podcast by KevinMD | Podcast
    • Preventive health care architecture: a global lesson

      Gerald Kuo | Conditions
    • Modern eugenics: the quiet return of a dangerous ideology

      Arthur Lazarus, MD, MBA | Physician
    • Telehealth stimulant conviction: lessons from the Done Global case

      Timothy Lesaca, MD | Conditions
  • Past 6 Months

    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • Patient modesty in health care matters

      Misty Roberts | Conditions
    • The U.S. gastroenterologist shortage explained

      Brian Hudes, MD | Physician
    • The Silicon Valley primary care doctor shortage

      George F. Smith, MD | Physician
    • California’s opioid policy hypocrisy

      Kayvan Haddadan, MD | Conditions
    • A lesson in empathy from a young patient

      Dr. Arshad Ashraf | Physician
  • Recent Posts

    • How should kratom be regulated? [PODCAST]

      The Podcast by KevinMD | Podcast
    • Physician leadership communication tips

      Imamu Tomlinson, MD, MBA | Physician
    • Why senior-friendly health materials are essential for access

      Gerald Kuo | Conditions
    • Why developmental and behavioral pediatrics faces a recruitment collapse

      Ronald L. Lindsay, MD | Physician
    • Valuing non-procedural physician skills

      Jennifer P. Rubin, MD | Physician
    • How genetic testing redefines motherhood [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Why feeling unlike yourself is a sign of physician emotional overload

      Stephanie Wellington, MD | Physician
    • Accountable care cooperatives: a community-owned health care fix

      David K. Cundiff, MD | Policy
    • How should kratom be regulated? [PODCAST]

      The Podcast by KevinMD | Podcast
    • Preventive health care architecture: a global lesson

      Gerald Kuo | Conditions
    • Modern eugenics: the quiet return of a dangerous ideology

      Arthur Lazarus, MD, MBA | Physician
    • Telehealth stimulant conviction: lessons from the Done Global case

      Timothy Lesaca, MD | Conditions
  • Past 6 Months

    • Direct primary care in low-income markets

      Dana Y. Lujan, MBA | Policy
    • Patient modesty in health care matters

      Misty Roberts | Conditions
    • The U.S. gastroenterologist shortage explained

      Brian Hudes, MD | Physician
    • The Silicon Valley primary care doctor shortage

      George F. Smith, MD | Physician
    • California’s opioid policy hypocrisy

      Kayvan Haddadan, MD | Conditions
    • A lesson in empathy from a young patient

      Dr. Arshad Ashraf | Physician
  • Recent Posts

    • How should kratom be regulated? [PODCAST]

      The Podcast by KevinMD | Podcast
    • Physician leadership communication tips

      Imamu Tomlinson, MD, MBA | Physician
    • Why senior-friendly health materials are essential for access

      Gerald Kuo | Conditions
    • Why developmental and behavioral pediatrics faces a recruitment collapse

      Ronald L. Lindsay, MD | Physician
    • Valuing non-procedural physician skills

      Jennifer P. Rubin, MD | Physician
    • How genetic testing redefines motherhood [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...